17β-estradiol eye drops protect the retinal ganglion cell layer and preserve visual function in an in vivo model of glaucoma

Molecular Pharmaceutics

Volumn 10, Issue 8, 2013, Pages 3253-3261

  Prokai Tatrai, Katalin ^a   Xin, Hua ^b   Nguyen, Vien ^a   Szarka, Szabolcs ^a   Blazics, Balazs ^a   Prokai, Laszlo ^a   Koulen, Peter ^b  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

17 estradiol; contrast sensitivity; estrogen quantitation; eye drop; glaucomatous retinopathy; LC MS MS; neuroprotection; rat model; retina proteomics; visual acuity

Indexed keywords

ESTRADIOL; ESTROGEN; EYE DROPS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CHEMICAL STRUCTURE; CONTROLLED STUDY; FEMALE; GLAUCOMA; INTRAOCULAR PRESSURE; MASS SPECTROMETRY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; RAT; RETINA; RETINA GANGLION CELL; UTERUS; VISION; VISUAL ACUITY;

ANIMALS; ESTRADIOL; GLAUCOMA; PROTEOMICS; RATS; RETINA; RETINAL GANGLION CELLS; VISUAL ACUITY;

EID: 84881323172     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp400313u     Document Type: Article

References (66)

1. Quigley, H. A.; Broman, A. T. The number of people with glaucoma worldwide in 2010 and 2020 Br. J. Ophthalmol. 2006, 90, 262-267
2. Schmidt, K. G.; Bergert, H.; Funk, R. H. Neurodegenerative diseases of the retina and potential for protection and recovery Curr. Neuropharmacol. 2008, 6, 164-178
3. Vasudevan, S. K.; Gupta, V.; Crowston, J. G. Neuroprotection in glaucoma Ind. J. Ophthalmol. 2011, 59, S102-S113
4. Chidlow, G.; Wood, J. P.; Casson, R. J. Pharmacological neuroprotection for glaucoma Drugs 2007, 67, 725-759
5. McKinnon, S. J. Glaucoma: Ocular Alzheimer's disease? Front. Biosci. 2003, 8, S1140-S1156
6. Guo, L.; Duggan, J.; Cordeiro, M. F. Alzheimer's disease and retinal neurodegeneration Curr. Alzheimer Res. 2012, 7, 3-14
7. Gupta, N.; Yücel, Y. H. Glaucoma as a neurodegenerative disease Curr. Opin. Ophthalmol. 2007, 18, 110-114
8. Chiu, K.; Chan, T. F.; Wu, A.; Yan-Pui Leung, I.; So, K. F.; Chuen-Chung Chang, R. Neurodegeneration of the retina in mouse models of Alzheimer's disease: what can we learn from the retina? Age 2012, 34, 633-649
9. Cordeiro, M. F.; Levin, L. A. Clinical evidence for neuroprotection in glaucoma Am. J. Ophthalmol. 2011, 152, 715-716
10. Levin, L. A. Retinal ganglion cells and neuroprotection for glaucoma Surv. Ophthalmol. 2003, 48, S21-S24
11. Casson, R. J. Possible role of excitotoxicity in the pathogenesis of glaucoma Clin. Exp. Ophthalmol. 2006, 34, 54-63
12. Zhou, X.; Li, F.; Kong, L.; Tomita, H.; Li, C.; Cao, W. Involvement of inflammation, degradation, and apoptosis in a mouse model of glaucoma J. Biol. Chem. 2005, 280, 31240-31248
13. Izzotti, A.; Bagnis, A.; SaccaÌ, S. C. The role of oxidative stress in glaucoma Mutat. Res. 2006, 612, 105-114
14. Kong, G. Y.; Van Bergen, N. J.; Trounce, I. A.; Crowston, J. G. Mitochondrial dysfunction and glaucoma J. Glaucoma 2009, 18, 93-100
15. Fang, J.; Jiang, F.; Li, J.; Zhu, Y. Rationale for the use of multifunctional drugs as neuroprotective agents for glaucoma Neural Regen. Res. 2011, 6, 313-318
16. Tsai, J. C. Medication adherence in glaucoma: approaches for optimizing patient compliance Curr. Opin. Ophthalmol. 2006, 17, 190-195
17. Guo, J. B.; Duckles, S. P.; Weiss, J. H.; Li, X. J.; Krause, D. N. 17 beta-Estradiol prevents cell death and mitochondrial dysfunction by an estrogen receptor-dependent mechanism in astrocytes after oxygen-glucose deprivation/reperfusion Free Radical Biol. Med. 2012, 52, 2151-2160
18. Spence, R. D.; Voskuhl, R. R. Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration Front. Neuroendocrinol. 2012, 33, 105-115
19. Ritzel, R. M.; Capozzi, L. A.; McCullough, L. D. Sex, stroke, and inflammation: The potential for estrogen-mediated immunoprotection in stroke Hormones Behav. 2013, 63, 238-253
20. Deschenes, M. C.; Descovich, D.; Moreau, M. Postmenopausal hormone therapy increases retinal blood flow and protects the retinal nerve fiber layer Invest. Ophthalmol. Vis. Sci. 2010, 51, 2587-2600
21. Bigsby, R. M.; Cardenas, H.; Caperell-Grant, C.; Grubbs, C. J. Protective effects of estrogen in a rat model of age-related cataracts Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 9328-9332
22. Yamashita, H.; Sugihara, K.; Yamada, C.; Tsutsumi, S.; Iwaki, Y. Effect of estrogen on electroretinographic responses in streptozotocin-induced diabetic female rats Exp. Eye Res. 2010, 90, 591-597
23. Zhou, X.; Li, F.; Ge, J.; Sarkisian, S. R., Jr.; Tomita, H.; Zaharia, A.; Chodosh, C.; Cao, W. Retinal ganglion cell protection by 17-beta-estradiol in a mouse model of inherited glaucoma Dev. Neurobiol. 2007, 67, 603-616
24. Nonaka, A.; Kiryu, J.; Tsujikawa, A.; Yamashiro, K.; Miyamoto, K.; Nishiwaki, H.; Mandai, M.; Honda, Y.; Ogura, Y. Administration of 17-beta-estradiol attenuates retinal ischemia-reperfusion injury in rats Ophthalmol. Vis. Sci. 2000, 41, 2689-2696
25. Wickham, L. A.; Gao, J.; Toda, I.; Rocha, E. M.; Ono, M.; Sullivan, D. A. Identification of androgen, estrogen and progesterone receptor mRNAs in the eye Acta Ophthalmol. Scand. 2000, 78, 146-153
26. Kobayashi, K.; Kobayashi, H.; Ueda, M.; Honda, Y. Estrogen receptor expression in bovine and rat retinas Invest. Ophthalmol. Vis. Sci. 1998, 39, 2105-2510
27. Kaja, S.; Yang, S. H.; Wei, J.; Fujitani, K.; Liu, R.; Brun-Zinkernagel, A. M.; Simpkins, J. W.; Inokuchi, K.; Koulen, P. Estrogen protects retinal ganglion cells from ischemia-induced loss of Vesl-1L/Homer 1c immunoreactive synaptic connections and from apoptosis in vivo Invest. Ophthal. Vis. Sci. 2003, 44, 3155-3162
28. Russo, R.; Cavaliere, F.; Watanabe, C.; Nucci, C.; Bagetta, G.; Corasaniti, M. T.; Sakurada, S.; Morrone, L. A. 17β-Estradiol prevents retinal ganglion cell loss induced by acute rise of intraocular pressure in rat Prog. Brain Res. 2008, 173, 583-590
29. Giddabasappa, A.; Bauler, M.; Yepuru, M.; Chaum, E.; Dalton, J. T.; Eswaraka, J. 17-β estradiol protects ARPE-19 cells from oxidative stress through estrogen receptor-β Invest. Ophthalmol. Vis. Sci. 2012, 51, 5278-5287
30. Neumann, F.; Wurm, A.; Linnertz, R.; Pannicke, T.; Iandiev, I.; Wiedemann, P.; Reichenbach, A.; Bringmann, A. Sex steroids inhibit osmotic swelling of retinal glial cells Neurochem. Res. 2010, 35, 522-530
31. Chen, X.-F.; Zhang, M.-N.; Jiang, C.-H.; Guo, W.; Liu, H.-Z.; Wei, S.-H. Estrogen attenuates VEGF-initiated blood-retina barrier breakdown in male rats Horm. Metab. Res. 2011, 43, 614-618
32. Vajaranant, T. S.; Pasquale, L. R. Estrogen deficiency accelerates aging of the optic nerve Menopause-J. N. Am. Menop. Soc. 2012, 19, 942-947
33. Dahan, A.; Miller, J. M.; Hoffman, A.; Amidon, G. E.; Amidon, G. L. The solubility-permeability interplay in using cyclodextrins as pharmaceutical solubilizers: Mechanistic modeling and application to progesterone J. Pharm. Sci. 2010, 99, 2739-2749
34. Wang, S.; Li, D.; Ito, Y.; Liu, X.; Zhang, J.; Wu, C. An ocular drug delivery system containing zinc diethyldithiocarbamate and HPbetaCD inclusion complex - corneal permeability, anti-cataract effects and mechanism studies J. Pharm. Pharmacol. 2004, 56, 1251-1257
35. Gould, S.; Scott, R. C. 2-Hydroxypropyl-β-cyclodextrin (HP-β-CD): A toxicology review Food Chem. Toxicol. 2005, 43, 1451-1459
36. Morrison, J. C.; Moore, C. G.; Deppmeier, L. M.; Gold, B. G.; Meshul, C. K.; Johnson, E. C. A rat model of chronic pressure-induced optic nerve damage Exp. Eye Res. 1997, 4, 85-96
37. Szarka, S.; Nguyen, V.; Prokai, L.; Prokai-Tatrai, K. Separation of dansylated 17β-estradiol, 17α-estradiol and estrone on a single HPLC column for simultaneous quantitation by LC-MS/MS Anal. Bioanal. Acta 2013, 405, 3399-3406
38. Prokai, L.; Stevens, S. M., Jr.; Rauniyar, N.; Nguyen, V. Rapid label-free identification of estrogen-induced differential protein expression in vivo from mouse brain and uterine tissue J. Proteome Res. 2009, 8, 3862-3871
39. Morrison, J. C.; Nylander, K. B.; Lauer, A. K.; Cepurna, W. O.; Johnson, E. Glaucoma drops control intraocular pressure and protect optic nerves in a rat model of glaucoma Invest. Ophtalmol. Vis. Sci. 1998, 39, 526-531
40. Cowley, A.; Franzini, C. The retinal origin of uncrossed optic nerve fibers in rats and their role in visual discrimination Exp. Brain Res. 1979, 35, 443-456
41. Douglas, R. M.; Alam, N. M.; Silver, B. D.; McGill, T. J.; Tschetter, W. W.; Prusky, G. T. Independent visual threshold measurements in the two eyes of freely moving rats and mice using a virtual-reality optokinetic system Vis. Neurosci. 2005, 22, 677-684
42. Prusky, G. T.; Alam, N. M.; Beekman, S.; Douglas, R. M. Rapid quantification of adult and developing mouse spatial vision using a virtual optomotor system Invest. Ophtalmol. Vis. Sci. 2004, 45, 4611-4616
43. Burroughs, S. L.; Kaja, S.; Koulen, P. Quantification of deficits in spatial visual function of mouse models for glaucoma Invest. Ophthalmol. Vis. Sci. 2011, 52, 3654-3659
44. Jellali, A.; Meziane, H.; Ouagazzal, A. M.; Rousseau, S.; Romand, R.; Auwerx, J.; Sahel, J.; Chambon, P.; Picaud, S. The optomotor response: A robust first-line visual screening method for mice Vision Res. 2005, 45, 1439-1446
45. Xin, H.; Yannazzo, JA-A.; Duncan, R. S.; Gregg, E. V.; Singh, M.; Koulen, P. A novel organotypic culture model of the postnatal mouse retina allows the study of glutamate-mediated excitotoxicity J. Neurosci. Methods 2007, 159, 35-42
46. Osborne, N. N.; Wood, J. P. M.; Chidlow, G.; Bae, J.-H.; Melena, J.; Nash, M. S. Ganglion cell death in glaucoma: what do we really know? Br. J. Ophthalmol. 1999, 83, 980-986
47. Kelly, K. J.; Sandoval, R. M.; Dunn, K. W.; Molitoris, B. A.; Dagher, P. C. A novel method to determine specificity and sensitivity of the TUNEL reaction in the quantitation of apoptosis Am. J. Physiol. Cell. Physiol. 2003, 284, C1309-1318
48. Prokai, L.; Szarka, S.; Wang, X.; Prokai-Tatrai, K. Capture of the volatile carbonyl metabolite of flecainide on 2,4-dinitrophenylhydrazine cartridge for quantitation by stable-isotope dilution mass spectrometry coupled with chromatography J. Chromatogr., A 2012, 1232, 281-287
49. Cascioa, C.; Russoa, D.; Dragoa, G.; Galizzia, G.; Passantinoa, R.; Guarneria, R.; Guarneri, P. 17β-Estradiol synthesis in the adult male rat retina Exp. Eye Res. 2007, 85, 166-172
50. Andley, U. P. Crystallins in the eye: function and pathology Prog. Retin. Eye Res. 2007, 26, 78-98
51. Munemasa, Y.; Kwong, J. M.; Caprioli, J.; Piri, N. The role of αA- and αB-crystallins in the survival of retinal ganglion cells after optic nerve axotomy Invest. Ophthalmol. Vis. Sci. 2009, 50, 3869-3875
52. Yaung, J.; Kannan, R.; Wawrousek, E. F.; Spee, C.; Sreckumar, P. G.; Hinton, D. R. Exacerbation of retinal degeneration in the absence of alpha crystallins in an in vivo model of chemically induced hypoxia Exp. Eye Res. 2008, 86, 355-365
53. D'Anna, C.; Cascio, C.; Cigna, D.; Galizzi, G.; Deidda, I.; Bianchi, L.; Russo, D.; Passantino, R.; Bini, L.; Guarneri, P. A retinal proteomics-based study identifies αA-Crystallin as a sex steroid-regulated protein Proteomics 2011, 11, 986-990
54. Liedtke, T.; Schwamborn, J. C.; Schroer, U.; Thanos, S. Elongation of axons during regeneration involves retinal crystallin β-b2 (crybb2) Mol. Cell. Proteomics 2007, 6, 895-907
55. Hoppe, G.; Rayborn, M. E.; Sears, J. E. Diurnal rhythm of the chromatin protein Hmgb1 in rat photoreceptors is under circadian regulation J. Comp. Neurol. 2007, 501, 219-230
56. Franke, A. G.; Gubbe, C.; Beier, M.; Duenker, N. Transforming growth factor-beta and bone morphogenetic proteins: Cooperative players in chick and murine programmed retinal cell death J. Comp. Neurol. 2006, 495, 263-278
57. Perkins, P. S.; Young, R. W. Histone proteins in fetal and adult human retinas Jpn. J. Ophthalmol. 1987, 31, 590-597
58. Makino, C. L.; Wen, X.; Michaud, N. A.; Covington, H. I.; DiBenedetto, E.; Hamm, H. E.; Lem, J.; Caruso, G. Rhodopsin expression level affects rod outer segment morphology and photoresponse kinetics PLoS ONE 2012, 7, e37832
59. Caruso, G.; Bisegna, P.; Shen, L.; Andreucci, D.; Hamm, H. E.; DiBenedetto, E. Modeling the role of incisures in vertebrate phototransduction Biophys. J. 2006, 91, 1192-1212
60. Clarke, G.; Goldberg, A. F.; Vidgen, D.; Collins, L.; Ploder, L.; Schwarz, L.; Molday, L. L.; Rossant, J.; Szel, A.; Molday, R. S.; Birch, D. G.; McInnes, R. R. Rom-1 is required for rod photoreceptor viability and the regulation of disk morphogenesis Nat. Genet. 2000, 25, 67-73
61. Hayashi, K.; Cheng, H. M.; Xiong, J.; Xiong, H.; Kenyon, K. R. Metabolic changes in the cornea of vitamin A-deficient rats Invest. Ophthalmol. Vis. Sci. 1989, 30, 769-772
62. Prentice, R. L.; Anderson, G. L. The women's health initiative: Lessons learned Annu. Rev. Public Health 2008, 29, 131-150
63. Gaudana, R.; Ananthula, H. K.; Parenky, A.; Mitra, A. K. Ocular drug delivery AAPS J. 2010, 12, 348-360
64. Owens, J. W.; Ashby, J. Critical review and evaluation of the uterotrophic bioassay for the identification of possible estrogen agonists and antagonists: In support of the validation of the OECD uterotrophic protocols for the laboratory rodent Crit. Rev. Toxicol. 2002, 32, 445-520
65. Prokai-Tatrai, K.; Szarka, S.; Nguyen, V.; Sahyouni, F.; Walker, C.; White, S.; Talamantes, T.; Prokai, L. "All in the mind"? Brain-targeting chemical delivery system of 17β-estradiol (Estredox) produces significant uterotrophic side effect. Pharm. Anal. Acta 2012, 10.4172/2153-2435.S7-002.
66. Wei, X.; Cai, S.; Zhang, X.; Li, X.; Chen, X.; Liu, L. Is low dose of estrogen beneficial for prevention of glaucoma? Med. Hypothesis 2012, 79, 377-380